Our Sponsors

Platinum Sponsor

Medtronic’s Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world.

In everything we do, we are engineering the extraordinary.

Medtronic is proud to partner with Hypertension Australia as platinum sponsors in 2024. As a leader in innovative medical technology, Medtronic is committed to transforming the treatment landscape for patients with hypertension. Medtronic aims to foster collaboration among clinicians, researchers, and industry stakeholders. Together, we can drive awareness and understanding of renal denervation’s potential to improve patient lives in Australia.

Gold Sponsor

Every day, millions of patients, caregivers, and healthcare providers rely on Baxter’s leading portfolio of diagnostic, critical care, nutrition, hospital, and surgical products used across patient homes, every hospital department, physician offices and other sites of care. For over 90 years, Baxter has been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen.

Baxter’s products, digital health solutions and therapies are available in more than 100 countries where Baxter employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.

With the acquisition of Welch Allyn, Baxter now proudly supplies the Connex range of patient monitors, offering BP averaging technology for improved detection of hypertension, and enhancing patient care through advanced monitoring technology, ensuring timely and accurate vital signs measurements.

Servier is an independent pharmaceutical company governed by a foundation. Free from shareholders, Servier is fully committed to discovering and delivering therapeutic progress to meet patient needs.

 Servier recognises the important efforts of the National Hypertension Taskforce and other key organisations to improve Australia’s BP control rate from 32% to 70% by 2030. As a key industry partner, we have provided support such as HCP and patient education, as well as projects and initiatives aimed at improving awareness, diagnosis, and treatment of hypertension.

Silver Sponsor

Machinery Forum Medical Systems has been providing quality Cardiology Medical Equipment and consumables since our founding in 1988.

Machinery Forum Medical Systems is a division of Machinery Forum Pty Ltd. The offices and service department is located in Melbourne.

It is our mission to provide medical equipment of outstanding quality and excellent customer support.

Lanyard Sponsor

Behind every treatment that improves human health is a story of discovery.
At the Monash Biomedicine Discovery Institute we are making the discoveries that will relieve the future burden of disease. Spanning six Discovery Programs – Cancer, Cardiovascular Disease, Development and Stem Cells, Infection and Immunity, Metabolism, Diabetes and Obesity, and Neuroscience and more than 120 research teams – we are one of the largest and highest-quality biomedical research institutes in Australia. This allows for the cross-pollination of ideas as it is at the intersection of these global health issues that genuinely innovative discoveries will be made.

ASM Support

CSL is a leading global biotechnology company with a portfolio of life-saving medicines, including those that treat haemophilia and immune deficiencies, as well as vaccines to prevent influenza. Since our start in 1916, we have been driven by our promise to save lives.

CSL is headquartered in Melbourne, Australia.  Our global R&D activities support our existing licensed products and development of new therapies that align with our technical and commercial capabilities in Immunology and Neurology, Haematology and Thrombosis, Transplant, Respiratory, Cardiovascular and Metabolic.  Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people.